Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eyecyte-PRP
- Development stage
- Preclinical
- Lead developer
- Eyestem Research
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Subretinal, Intravitreal
01
Overview
Eyecyte-PRP is an allogeneic cell therapy candidate composed of induced pluripotent stem cell (iPSC)-derived photoreceptor progenitor cells. Developed by the Indian biotechnology company Eyestem Research, it is specifically designed to treat Retinitis Pigmentosa (RP), a group of rare genetic disorders that cause the progressive degeneration of photoreceptor cells in the retina, leading to severe vision loss. The therapeutic strategy involves the surgical delivery of these progenitor cells into the subretinal space, where they are intended to integrate and replace lost or damaged photoreceptors, thereby potentially restoring visual function or halting disease progression. Eyecyte-PRP is the second product in Eyestem's pipeline, following their lead asset for Dry Age-related Macular Degeneration, and is currently in the preclinical stage of development.
- Brand names
- Eyecyte-PRP
Beyond the preview
Go deeper on Eyecyte-PRP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eyecyte-PRP.